• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠腺癌患者的心血管死亡风险:一项基于人群的研究。

Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study.

作者信息

Zhang Yao, Zeng Shicong, Wang Zongwen, Zhu Qiankun, Li Jingtao, Ren Xiaohang, Ma Shuoheng, Tan Gang, Zhai Bo

机构信息

Department of General Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.

Department of Intervention Radiology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.

出版信息

BMC Public Health. 2025 Jan 8;25(1):97. doi: 10.1186/s12889-025-21279-5.

DOI:10.1186/s12889-025-21279-5
PMID:39780085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11715972/
Abstract

BACKGROUND

The objective of this research is to statistically assess the risk of cardiovascular mortality (CVM) between patients with small bowel adenocarcinoma (SBA) and the general population. Additionally, it aims to identify CVM-associated risk factors among individuals with SBA.

METHODS

Data obtained between 2000 and 2017 on SBA patients from the Surveillance, Epidemiology, and End Results (SEER) database were examined. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were obtained to compare CVM between patients and the general US population. To evaluate the cumulative mortality (CM) rate for all causes of death (COD), cumulative hazard curves were constructed. Two multivariate competing risk models were established to determine the independent predictors for CVM.

RESULTS

In the cohort of 5,175 SBA patients observed for 15,068.24 person-years, a total of 205 deaths were attributed to cardiovascular disease (CVD). The overall SMR of CVM was 1.41 (95% confidence interval (CI): 1.23-1.62, P < 0.05), whereas it reached 2.99 during the early stage of latency. Additionally, independent risk factors for CVM included age, marital status, calendar year of diagnosis, disease differentiation degree, SEER stage, and chemotherapy status.

CONCLUSIONS

SBA patients exhibited a substantially elevated risk of developing CVM compared to the general US population. During the follow-up period, the CM rate for CVM continued to rise steadily. Timely identification of high-risk groups and effective interventions to safeguard cardiovascular health significantly improve patient prognosis.

摘要

背景

本研究的目的是通过统计学方法评估小肠腺癌(SBA)患者与普通人群之间心血管疾病死亡率(CVM)的风险。此外,旨在确定SBA患者中与CVM相关的风险因素。

方法

对2000年至2017年期间从监测、流行病学和最终结果(SEER)数据库中获取的SBA患者数据进行了检查。获得标准化死亡率(SMR)和绝对超额风险(AER),以比较患者与美国普通人群之间的CVM。为评估所有死因(COD)的累积死亡率(CM),构建了累积风险曲线。建立了两个多变量竞争风险模型,以确定CVM的独立预测因素。

结果

在观察了15068.24人年的5175例SBA患者队列中,共有205例死亡归因于心血管疾病(CVD)。CVM的总体SMR为1.41(95%置信区间(CI):1.23 - 1.62,P < 0.05),而在潜伏期早期达到2.99。此外,CVM的独立风险因素包括年龄、婚姻状况、诊断年份、疾病分化程度、SEER分期和化疗状态。

结论

与美国普通人群相比,SBA患者发生CVM的风险显著升高。在随访期间,CVM的CM率持续稳步上升。及时识别高危人群并采取有效的心血管健康干预措施可显著改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/901329e98683/12889_2025_21279_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/489e1a6706a9/12889_2025_21279_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/01ecfce6970b/12889_2025_21279_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/c9ec34a97fad/12889_2025_21279_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/c29317435b74/12889_2025_21279_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/768efefa527a/12889_2025_21279_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/901329e98683/12889_2025_21279_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/489e1a6706a9/12889_2025_21279_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/01ecfce6970b/12889_2025_21279_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/c9ec34a97fad/12889_2025_21279_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/c29317435b74/12889_2025_21279_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/768efefa527a/12889_2025_21279_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a7a/11715972/901329e98683/12889_2025_21279_Fig6_HTML.jpg

相似文献

1
Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study.小肠腺癌患者的心血管死亡风险:一项基于人群的研究。
BMC Public Health. 2025 Jan 8;25(1):97. doi: 10.1186/s12889-025-21279-5.
2
High cardiovascular mortality risk among older merkel cell carcinoma patients.老年 Merkel 细胞癌患者心血管死亡风险较高。
BMC Geriatr. 2024 Aug 9;24(1):670. doi: 10.1186/s12877-024-05222-8.
3
Long-term risks of cardiovascular-specific mortality among myeloproliferative neoplasms patients.骨髓增殖性肿瘤患者心血管特异性死亡的长期风险。
Ther Adv Hematol. 2024 Oct 28;15:20406207241290886. doi: 10.1177/20406207241290886. eCollection 2024.
4
Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis.胃肠胰神经内分泌肿瘤患者的心血管死亡率:基于登记的分析。
Oxid Med Cell Longev. 2021 Jun 26;2021:9985814. doi: 10.1155/2021/9985814. eCollection 2021.
5
Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.克罗恩病中小肠腺癌的预后与原发性小肠腺癌相比更有利。
Colorectal Dis. 2017 May;19(5):446-455. doi: 10.1111/codi.13531.
6
Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study.列线图预测小肠腺癌患者的生存情况:一项基于 SEER 的研究。
Int J Clin Oncol. 2021 Feb;26(2):387-398. doi: 10.1007/s10147-020-01813-8. Epub 2020 Oct 28.
7
Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.胃肠道间质瘤患者心血管特异性死亡率:基于人群的分析。
Oxid Med Cell Longev. 2023 Feb 14;2023:3619306. doi: 10.1155/2023/3619306. eCollection 2023.
8
Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: A SEER database analysis.肺典型类癌肿瘤心血管特异性死亡率的竞争风险分析:一项 SEER 数据库分析。
Medicine (Baltimore). 2023 Oct 6;102(40):e35104. doi: 10.1097/MD.0000000000035104.
9
Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.非霍奇金淋巴瘤患者的心血管死亡率:根据淋巴瘤亚型的差异。
Hematol Oncol. 2019 Aug;37(3):261-269. doi: 10.1002/hon.2607. Epub 2019 Apr 12.
10
Small bowel neuroendocrine tumors: Unique features and low lethality compared with small bowel adenocarcinoma.小肠神经内分泌肿瘤:与小肠腺癌相比的独特特征及低致死率
J Gastroenterol Hepatol. 2024 Dec;39(12):2597-2608. doi: 10.1111/jgh.16740. Epub 2024 Sep 16.

本文引用的文献

1
Risk classification for non-cancer death in middle-aged cancer patients.中年癌症患者非癌症死亡的风险分类
J Adv Res. 2024 Dec 25. doi: 10.1016/j.jare.2024.12.039.
2
Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers.21种非转移性癌症患者的长期和短期心血管疾病死亡率
J Adv Res. 2025 Mar;69:215-224. doi: 10.1016/j.jare.2024.03.017. Epub 2024 Mar 26.
3
Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study.膀胱癌患者的心血管疾病死亡风险:一项基于人群的研究。
J Cardiovasc Dev Dis. 2022 Aug 9;9(8):255. doi: 10.3390/jcdd9080255.
4
Risk factors associated with cardiovascular mortality among gastric cancer patients: a population-based analysis.胃癌患者心血管死亡的相关风险因素:基于人群的分析。
Jpn J Clin Oncol. 2022 Dec 5;52(12):1365-1374. doi: 10.1093/jjco/hyac132.
5
Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer.原发性胆囊癌患者心血管死亡的竞争风险分析。
Cancer Med. 2023 Feb;12(3):2179-2186. doi: 10.1002/cam4.5104. Epub 2022 Aug 3.
6
Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy.癌症与心血管疾病的代谢交集:癌症治疗的机遇。
Adv Exp Med Biol. 2021;1311:249-263. doi: 10.1007/978-3-030-65768-0_18.
7
Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study.结直肠癌诊断后的死亡原因:一项基于人群的研究。
Front Oncol. 2021 Mar 30;11:647179. doi: 10.3389/fonc.2021.647179. eCollection 2021.
8
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
9
Deaths: Final Data for 2017.死亡:2017年最终数据。
Natl Vital Stat Rep. 2019 Jun;68(9):1-77.
10
Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: a surveillance, epidemiology and end results (SEER) analysis.慢性髓性白血病患者在酪氨酸激酶抑制剂(TKI)时代前和 TKI 时代的心血管死亡率:监测、流行病学和最终结果(SEER)分析。
Leuk Lymphoma. 2020 May;61(5):1147-1157. doi: 10.1080/10428194.2019.1711074. Epub 2020 Jan 27.